Volume 13, Number 2—February 2007
Dispatch
Pneumocystis Pneumonia in HIV-positive Adults, Malawi1
Joep J.G. van Oosterhout*, Miriam K. Laufer†, M. Arantza Perez*, Stephen M. Graham*, Nelson Chimbiya*, Phillip C. Thesing*, Miriam J. Álvarez-Martinez‡, Paul E. Wilson‡, Maganizo Chagomerana*, Eduard E. Zijlstra*, Terrie E. Taylor*§, Christopher V. Plowe†
, and Steven R Meshnick‡
, and Steven R Meshnick‡
Table 1
Baseline characteristics of study participants at enrollment, Malawi, 2002–2004*
| Characteristic | No. episodes | PYO |
|---|---|---|
| CD4 (cells/mm3) | ||
| 0–99 | 125 | 83 |
| 100–199 | 159 | 145 |
| 200–499 | 271 | 268 |
| >500 | 77 | 75 |
| Missing at enrollment | 28 | 19 |
| HIV clinical stage† | ||
| I | 267 | 255 |
| II | 191 | 190 |
| III | 160 | 120 |
| IV | 42 | 25 |
| Total | 660 | 591 |
*PYO, person-years of observation (based on enrollment characteristics).
†As defined by World Health Organization criteria.
1Data from this study were presented in part at 9th College of Medicine Research Dissemination Conference, Blantyre, Malawi, 12 Nov 2005 (abstract DCON/05/44), and XV International AIDS Conference, Bangkok, Thailand, 11–16 Jul 2004 (abstract MoPeB3198).
Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.